Loading...

ELISA MAX™ Deluxe Set Mouse IFN-γ ELISA MAX™ Deluxe Set Mouse IFN-γ

Pricing & Availability
Regulatory Status
RUO
Other Names
IFN-g ELISA Kit
Ave. Rating
Submit a Review
Product Citations
publications
mouse ifn-g_122109
  • mouse ifn-g_122109
Cat # Size Price Quantity Check Availability Save
430804 5 plates DKK1812
Check Availability


Need larger quantities of this item?
Request Bulk Quote
430815 10 Plates DKK3481
Check Availability


Need larger quantities of this item?
Request Bulk Quote
430816 20 Plates DKK5572
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

ELISA Development Systems Engineered for Sensitive, Precise and Reliable Serum and Plasma Cytokine Quantitation

BioLegend's ELISA MAX™ Sets provide all the time-savings, convenience and performance of a high-end, commercial ELISA kit for a fraction of the price!

BioLegend's ELISA MAX™ Sets, in two appealing formats, address the need for sensitivity, accuracy, dependability, and versatility of an ELISA development system, while providing maximum cost effectiveness, value, and ease of use.

Both the ELISA MAX™ Set Standard and ELISA MAX™ Set Deluxe are specifically engineered for accurate recovery and measurement of analytes in complex fluids, such as serum and plasma (as well as activated cell cultures) without any interference by confounding serum factors, such as heterophilic antibody or rheumatoid factor.

Product Details
Technical Data Sheet (pdf)

Kit Details

Kit Contents
  • Mouse IFN-γ ELISA MAX™ Capture Antibody (200X)
  • Mouse IFN-γ ELISA MAX™ Detection Antibody (200X)
  • Mouse IFN-γ Standard
  • Avidin-HRP (1000X)
  • Substrate Solution F
  • Coating Buffer A (5X)
  • Assay Diluent A (5X)
Materials Not Included
  • Microwell plates: 96-well Nunc MaxiSorp™ is recommended.
  • A microplate reader capable of measuring absorbance at 450 nm
  • Adjustable pipettes to measure volumes ranging from 2 µL to 1 mL
  • Deionized (DI) water
  • PBS (Phosphate-Buffered Saline): 8.0 g NaCl, 1.16 g Na2HPO4, 0.2 g KH2PO4, 0.2 g KCl, add deionized water to 1 L; pH to 7.4, 0.2 µm filtered.
  • Wash Buffer (Phosphate-Buffered Saline (PBS) + 0.05% Tween-20, pH=7.4). BioLegend Cat. No. 421601 is recommended.
  • Wash bottle or automated microplate washer
  • Stop Solution (e.g. 2N H2SO4) Biolegend Cat. No. 423001 is recommended
  • Log-Log graph paper or software for data analysis
  • Tubes to prepare standard dilutions
  • Timer
  • Plate Sealer
  • Absorbent paper

Product Details

Verified Reactivity
Mouse
Application

ELISA
 
As a part of BioLegend's efforts to go green, each new lot of the ELISA MAX™ sets will include a summarized version of its manual. Click here for more information.
Application Notes

The assay kits will no longer include ELISA microwell plates. Recommended microwell plates can be purchased separately under Cat. No. 423501. Please contact your BioLegend sales representative for bulk pricing quotations.

Application References
  1. Lau AH, et al. 2006. J. Leukoc. Biol. 79:941.
  2. Inoue Y, et al. 2007. J. Immunol. 179:764.
  3. Perchonock CE, et al. 2007. J. Immunol. 179:1768.
  4. Perruche S, et al. 2009. J. Immunol. 183:953. PubMed
  5. Tallima H, et. al. 2009. Cytokine 48:239. PubMed
  6. Zhang Y, et al. 2010. Infect Immun. 78:2329. PubMed
  7. El Ridi R, et al. 2010. Microbes Infect. epub. PubMed
  8. McPhee JB, et al. 2010. Infect Immun. PubMed
  9. Yu M, et al. 2011. Vaccine. 29:2429. PubMed
  10. Puangpetch A, et al. 2012. Clin Vaccine Immunol. 19:675. PubMed.
Product Citations
  1. Madrid-Paulino E, et al. 2022. J Leukoc Biol. 112:475. PubMed
  2. Luo WJ, et al. 2022. Elife. 11: . PubMed
  3. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  4. Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed
  5. Sillibourne JE, et al. 2022. Biotechniques. 72:143. PubMed
  6. Nakka K, et al. 2022. Science. 377:666. PubMed
  7. Tubiana J, et al. 2022. Cell Rep. 41:111512. PubMed
  8. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  9. Mooney JP, et al. 2022. Wellcome Open Res. 7:134. PubMed
  10. Klement JD, et al. 2018. J Clin Invest. 128:5549. PubMed
  11. Puangpetch A, et al. 2012. Clin Vaccine Immunol. 1.260416667. PubMed
  12. Perruche S, et al. 2009. J Immunol. 183:953. PubMed
  13. Chen M, et al. 2022. J Nanobiotechnology. 20:273. PubMed
  14. Xu B, et al. 2021. Front Immunol. 11:583510. PubMed
  15. Radwanska M, et al. 2021. Vaccines (Basel). 9:. PubMed
  16. Zhou T, et al. 2020. Nature. 583:609. PubMed
  17. Yu M, Vajdy M 2011. Vaccine. 29:2429. PubMed
  18. Puca E, et al. 2020. J Gastrointest Oncol. 1.015972222. PubMed
  19. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  20. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  21. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  22. McPhee J, et al. 2010. Infect Immun. 78:3529. PubMed
  23. Daher C, et al. 2019. Cancer Immunol Res. 1.575694444. PubMed
  24. Sun Z, et al. 2020. Front Immunol. 1.568055556. PubMed
  25. Park GT, et al. 2021. Mar Drugs. 19:. PubMed
  26. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  27. Leroux LP, et al. 2020. Front Cell Infect Microbiol. 0.755555556. PubMed
  28. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  29. Wang J, et al. 2022. J Clin Invest. :. PubMed
  30. Park GT, et al. 2019. Front Immunol. 10:2095. PubMed
  31. Ci T, et al. 2020. Sci Adv. 6:00. PubMed
  32. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  33. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  34. Bliska Y 2010. Infect Immun. 78:2359. PubMed
  35. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  36. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  37. Garrido V, et al. 2021. Mol Syst Biol. 17:e10145. PubMed
  38. Fernandes RA, et al. 2020. Nature. 779:586. PubMed
  39. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  40. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  41. Gu BH, et al. 2022. Biomedicines. 10:. PubMed
  42. Shi D, et al. 2022. Nat Commun. 13:5644. PubMed
  43. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  44. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  45. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  46. Waaler J, et al. 2020. Commun Biol. 3:196. PubMed
  47. Reed MD, et al. 2020. Nature. 577:249. PubMed
  48. Chaudhari R, et al. 2021. Nanomaterials (Basel). 11:. PubMed
  49. Madrid-Paulino E, et al. 2022. J Leukoc Biol. 112:475. PubMed
  50. Luo WJ, et al. 2022. Elife. 11: . PubMed
  51. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  52. Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed
  53. Sillibourne JE, et al. 2022. Biotechniques. 72:143. PubMed
  54. Nakka K, et al. 2022. Science. 377:666. PubMed
  55. Tubiana J, et al. 2022. Cell Rep. 41:111512. PubMed
  56. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  57. Mooney JP, et al. 2022. Wellcome Open Res. 7:134. PubMed
  58. Klement JD, et al. 2018. J Clin Invest. 128:5549. PubMed
  59. Puangpetch A, et al. 2012. Clin Vaccine Immunol. 1.260416667. PubMed
  60. Perruche S, et al. 2009. J Immunol. 183:953. PubMed
  61. Chen M, et al. 2022. J Nanobiotechnology. 20:273. PubMed
  62. Xu B, et al. 2021. Front Immunol. 11:583510. PubMed
  63. Radwanska M, et al. 2021. Vaccines (Basel). 9:. PubMed
  64. Zhou T, et al. 2020. Nature. 583:609. PubMed
  65. Yu M, Vajdy M 2011. Vaccine. 29:2429. PubMed
  66. Puca E, et al. 2020. J Gastrointest Oncol. 1.015972222. PubMed
  67. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  68. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  69. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  70. McPhee J, et al. 2010. Infect Immun. 78:3529. PubMed
  71. Daher C, et al. 2019. Cancer Immunol Res. 1.575694444. PubMed
  72. Sun Z, et al. 2020. Front Immunol. 1.568055556. PubMed
  73. Park GT, et al. 2021. Mar Drugs. 19:. PubMed
  74. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  75. Leroux LP, et al. 2020. Front Cell Infect Microbiol. 0.755555556. PubMed
  76. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  77. Wang J, et al. 2022. J Clin Invest. :. PubMed
  78. Park GT, et al. 2019. Front Immunol. 10:2095. PubMed
  79. Ci T, et al. 2020. Sci Adv. 6:00. PubMed
  80. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  81. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  82. Bliska Y 2010. Infect Immun. 78:2359. PubMed
  83. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  84. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  85. Garrido V, et al. 2021. Mol Syst Biol. 17:e10145. PubMed
  86. Fernandes RA, et al. 2020. Nature. 779:586. PubMed
  87. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  88. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  89. Gu BH, et al. 2022. Biomedicines. 10:. PubMed
  90. Shi D, et al. 2022. Nat Commun. 13:5644. PubMed
  91. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  92. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  93. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  94. Waaler J, et al. 2020. Commun Biol. 3:196. PubMed
  95. Reed MD, et al. 2020. Nature. 577:249. PubMed
  96. Chaudhari R, et al. 2021. Nanomaterials (Basel). 11:. PubMed
Sensitivity
4 pg/mL
Standard Range
15.6-1,000 pg/mL

Antigen Details

Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Type
Tregs
Biology Area
Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

Related FAQs

Do the ELISA MAX™ Deluxe Sets come with plates?

No, ELISA MAX™ Deluxe Sets do not come with plates. Coating Buffer and Assay Diluent (for blocking and dilutions) are included in these sets. Plates can be ordered separately (Cat No. 423501), and instructions for coating the plates are in the sets’ product manuals.

Go To Top Version: 4    Revision Date: 11/17/2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
IFN-g ELISA Kit
Ave. Rating
Submit a Review
Product Citations
publications
mouse ifn-g_122109
  • mouse ifn-g_122109
Cat # Size Price Quantity Check Availability Save
430804 5 plates DKK1812
Check Availability


Need larger quantities of this item?
Request Bulk Quote
430815 10 Plates DKK3481
Check Availability


Need larger quantities of this item?
Request Bulk Quote
430816 20 Plates DKK5572
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

ELISA Development Systems Engineered for Sensitive, Precise and Reliable Serum and Plasma Cytokine Quantitation

BioLegend's ELISA MAX™ Sets provide all the time-savings, convenience and performance of a high-end, commercial ELISA kit for a fraction of the price!

BioLegend's ELISA MAX™ Sets, in two appealing formats, address the need for sensitivity, accuracy, dependability, and versatility of an ELISA development system, while providing maximum cost effectiveness, value, and ease of use.

Both the ELISA MAX™ Set Standard and ELISA MAX™ Set Deluxe are specifically engineered for accurate recovery and measurement of analytes in complex fluids, such as serum and plasma (as well as activated cell cultures) without any interference by confounding serum factors, such as heterophilic antibody or rheumatoid factor.

Product Details
Technical Data Sheet (pdf)

Kit Details

Kit Contents
  • Mouse IFN-γ ELISA MAX™ Capture Antibody (200X)
  • Mouse IFN-γ ELISA MAX™ Detection Antibody (200X)
  • Mouse IFN-γ Standard
  • Avidin-HRP (1000X)
  • Substrate Solution F
  • Coating Buffer A (5X)
  • Assay Diluent A (5X)
Materials Not Included
  • Microwell plates: 96-well Nunc MaxiSorp™ is recommended.
  • A microplate reader capable of measuring absorbance at 450 nm
  • Adjustable pipettes to measure volumes ranging from 2 µL to 1 mL
  • Deionized (DI) water
  • PBS (Phosphate-Buffered Saline): 8.0 g NaCl, 1.16 g Na2HPO4, 0.2 g KH2PO4, 0.2 g KCl, add deionized water to 1 L; pH to 7.4, 0.2 µm filtered.
  • Wash Buffer (Phosphate-Buffered Saline (PBS) + 0.05% Tween-20, pH=7.4). BioLegend Cat. No. 421601 is recommended.
  • Wash bottle or automated microplate washer
  • Stop Solution (e.g. 2N H2SO4) Biolegend Cat. No. 423001 is recommended
  • Log-Log graph paper or software for data analysis
  • Tubes to prepare standard dilutions
  • Timer
  • Plate Sealer
  • Absorbent paper

Product Details

Verified Reactivity
Mouse
Application

ELISA
 
As a part of BioLegend's efforts to go green, each new lot of the ELISA MAX™ sets will include a summarized version of its manual. Click here for more information.
Application Notes

The assay kits will no longer include ELISA microwell plates. Recommended microwell plates can be purchased separately under Cat. No. 423501. Please contact your BioLegend sales representative for bulk pricing quotations.

Application References
  1. Lau AH, et al. 2006. J. Leukoc. Biol. 79:941.
  2. Inoue Y, et al. 2007. J. Immunol. 179:764.
  3. Perchonock CE, et al. 2007. J. Immunol. 179:1768.
  4. Perruche S, et al. 2009. J. Immunol. 183:953. PubMed
  5. Tallima H, et. al. 2009. Cytokine 48:239. PubMed
  6. Zhang Y, et al. 2010. Infect Immun. 78:2329. PubMed
  7. El Ridi R, et al. 2010. Microbes Infect. epub. PubMed
  8. McPhee JB, et al. 2010. Infect Immun. PubMed
  9. Yu M, et al. 2011. Vaccine. 29:2429. PubMed
  10. Puangpetch A, et al. 2012. Clin Vaccine Immunol. 19:675. PubMed.
Product Citations
  1. Madrid-Paulino E, et al. 2022. J Leukoc Biol. 112:475. PubMed
  2. Luo WJ, et al. 2022. Elife. 11: . PubMed
  3. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  4. Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed
  5. Sillibourne JE, et al. 2022. Biotechniques. 72:143. PubMed
  6. Nakka K, et al. 2022. Science. 377:666. PubMed
  7. Tubiana J, et al. 2022. Cell Rep. 41:111512. PubMed
  8. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  9. Mooney JP, et al. 2022. Wellcome Open Res. 7:134. PubMed
  10. Klement JD, et al. 2018. J Clin Invest. 128:5549. PubMed
  11. Puangpetch A, et al. 2012. Clin Vaccine Immunol. 1.260416667. PubMed
  12. Perruche S, et al. 2009. J Immunol. 183:953. PubMed
  13. Chen M, et al. 2022. J Nanobiotechnology. 20:273. PubMed
  14. Xu B, et al. 2021. Front Immunol. 11:583510. PubMed
  15. Radwanska M, et al. 2021. Vaccines (Basel). 9:. PubMed
  16. Zhou T, et al. 2020. Nature. 583:609. PubMed
  17. Yu M, Vajdy M 2011. Vaccine. 29:2429. PubMed
  18. Puca E, et al. 2020. J Gastrointest Oncol. 1.015972222. PubMed
  19. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  20. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  21. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  22. McPhee J, et al. 2010. Infect Immun. 78:3529. PubMed
  23. Daher C, et al. 2019. Cancer Immunol Res. 1.575694444. PubMed
  24. Sun Z, et al. 2020. Front Immunol. 1.568055556. PubMed
  25. Park GT, et al. 2021. Mar Drugs. 19:. PubMed
  26. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  27. Leroux LP, et al. 2020. Front Cell Infect Microbiol. 0.755555556. PubMed
  28. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  29. Wang J, et al. 2022. J Clin Invest. :. PubMed
  30. Park GT, et al. 2019. Front Immunol. 10:2095. PubMed
  31. Ci T, et al. 2020. Sci Adv. 6:00. PubMed
  32. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  33. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  34. Bliska Y 2010. Infect Immun. 78:2359. PubMed
  35. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  36. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  37. Garrido V, et al. 2021. Mol Syst Biol. 17:e10145. PubMed
  38. Fernandes RA, et al. 2020. Nature. 779:586. PubMed
  39. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  40. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  41. Gu BH, et al. 2022. Biomedicines. 10:. PubMed
  42. Shi D, et al. 2022. Nat Commun. 13:5644. PubMed
  43. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  44. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  45. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  46. Waaler J, et al. 2020. Commun Biol. 3:196. PubMed
  47. Reed MD, et al. 2020. Nature. 577:249. PubMed
  48. Chaudhari R, et al. 2021. Nanomaterials (Basel). 11:. PubMed
  49. Madrid-Paulino E, et al. 2022. J Leukoc Biol. 112:475. PubMed
  50. Luo WJ, et al. 2022. Elife. 11: . PubMed
  51. Cheng P, et al. 2023. Pharmacol Res. 188:106643. PubMed
  52. Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed
  53. Sillibourne JE, et al. 2022. Biotechniques. 72:143. PubMed
  54. Nakka K, et al. 2022. Science. 377:666. PubMed
  55. Tubiana J, et al. 2022. Cell Rep. 41:111512. PubMed
  56. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  57. Mooney JP, et al. 2022. Wellcome Open Res. 7:134. PubMed
  58. Klement JD, et al. 2018. J Clin Invest. 128:5549. PubMed
  59. Puangpetch A, et al. 2012. Clin Vaccine Immunol. 1.260416667. PubMed
  60. Perruche S, et al. 2009. J Immunol. 183:953. PubMed
  61. Chen M, et al. 2022. J Nanobiotechnology. 20:273. PubMed
  62. Xu B, et al. 2021. Front Immunol. 11:583510. PubMed
  63. Radwanska M, et al. 2021. Vaccines (Basel). 9:. PubMed
  64. Zhou T, et al. 2020. Nature. 583:609. PubMed
  65. Yu M, Vajdy M 2011. Vaccine. 29:2429. PubMed
  66. Puca E, et al. 2020. J Gastrointest Oncol. 1.015972222. PubMed
  67. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  68. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  69. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  70. McPhee J, et al. 2010. Infect Immun. 78:3529. PubMed
  71. Daher C, et al. 2019. Cancer Immunol Res. 1.575694444. PubMed
  72. Sun Z, et al. 2020. Front Immunol. 1.568055556. PubMed
  73. Park GT, et al. 2021. Mar Drugs. 19:. PubMed
  74. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  75. Leroux LP, et al. 2020. Front Cell Infect Microbiol. 0.755555556. PubMed
  76. Li Y, et al. 2021. Sci Transl Med. 13:. PubMed
  77. Wang J, et al. 2022. J Clin Invest. :. PubMed
  78. Park GT, et al. 2019. Front Immunol. 10:2095. PubMed
  79. Ci T, et al. 2020. Sci Adv. 6:00. PubMed
  80. Zeng Q, et al. 2022. iScience. 25:105151. PubMed
  81. Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
  82. Bliska Y 2010. Infect Immun. 78:2359. PubMed
  83. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  84. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  85. Garrido V, et al. 2021. Mol Syst Biol. 17:e10145. PubMed
  86. Fernandes RA, et al. 2020. Nature. 779:586. PubMed
  87. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  88. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  89. Gu BH, et al. 2022. Biomedicines. 10:. PubMed
  90. Shi D, et al. 2022. Nat Commun. 13:5644. PubMed
  91. Lanfermann C, et al. 2021. Vaccines (Basel). 9:. PubMed
  92. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  93. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  94. Waaler J, et al. 2020. Commun Biol. 3:196. PubMed
  95. Reed MD, et al. 2020. Nature. 577:249. PubMed
  96. Chaudhari R, et al. 2021. Nanomaterials (Basel). 11:. PubMed
Sensitivity
4 pg/mL
Standard Range
15.6-1,000 pg/mL

Antigen Details

Cell Sources
CD8+ and CD4+ T cells, NK cells
Cell Type
Tregs
Biology Area
Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Gene ID
15978 View all products for this Gene ID
UniProt
View information about IFN-gamma on UniProt.org

Related FAQs

Do the ELISA MAX™ Deluxe Sets come with plates?

No, ELISA MAX™ Deluxe Sets do not come with plates. Coating Buffer and Assay Diluent (for blocking and dilutions) are included in these sets. Plates can be ordered separately (Cat No. 423501), and instructions for coating the plates are in the sets’ product manuals.

Go To Top Version: 4    Revision Date: 11/17/2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account